Streetbeat News

Analyst Ratings

REPL

JP Morgan analyst Anupam Rama has maintained an Overweight rating on Replimune Group and raised the price target from $14 to $17.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 1:54 pm

MCK

McKesson's stock is trading lower following a downgrade by Baird from Outperform to Neutral, with a reduced price target from $603 to $531.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 1:52 pm

BNTX

BioNTech shares rise as Morgan Stanley upgrades the stock from Equal-Weight to Overweight, increasing the price target from $93 to $145.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 1:49 pm

REGN

Truist Securities has reiterated its Buy rating for Regeneron Pharmaceuticals, maintaining a price target of $1200.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 1:49 pm

CEG

Barclays analyst Nicholas Campanella maintains an Overweight rating on Constellation Energy and raises the price target from $211 to $280.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 1:47 pm

MNSO

MINISO Group shares declined following a downgrade by Jefferies from Buy to Hold.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 1:47 pm

CVNA

Deep-pocketed investors are showing a bearish sentiment towards Carvana (NYSE:CVNA), with 62% of options activity being bearish. This significant move suggests potential price volatility. Analysts have mixed ratings, with price targets ranging from $157 to $200.

Portfolio Pulse from Benzinga Insights

September 24, 2024 | 1:46 pm

MSTR

Financial giants have shown a bullish interest in MicroStrategy (NASDAQ:MSTR) options, with 14 unusual trades identified. The trading activity suggests a price target range of $110 to $380. Analysts have mixed ratings, with price targets ranging from $146 to $200.

Portfolio Pulse from Benzinga Insights

September 24, 2024 | 1:45 pm

ZVRA

Zevra Therapeutics shares rose after announcing positive Phase 2 trial results for KP1077 in idiopathic hypersomnia. Maxim Group and Roth MKM raised price targets, and JMP Securities initiated coverage with a Market Outperform rating.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 1:45 pm

NTR

Wells Fargo has downgraded Nutrien (NYSE:NTR) from Overweight to Equal-Weight and reduced its price target from $62 to $50.

Portfolio Pulse from Benzinga Newsdesk

September 24, 2024 | 1:41 pm